Leading royalty acquisition firm providing non-dilutive capital solutions to commercial and near-commercial biopharmaceutical companies. Majority owned by KKR.

Stamford · 1+ investments · 1 portfolio companies

Late Stage
Growth
Healthcare
biotechnology
pharmaceuticals
Headquarters
Stamford
Founded
2006
Website
hcrx.com
Portfolio Company
1
Total Investment
1
Last Investment
Jun 2025
Geographic Focus
United Kingdom, United States

Investment Thesis

Acquires royalty streams and provides debt financing to biopharma companies with commercial-stage assets, targeting sustainable revenue-generating products with high barriers to entry.

HCRx is a Venture Capital firm based in Stamford. It has made 1 investment, including BridgeBio. Focus areas include Healthcare and biotechnology.

Portfolio1

Co-investors16

Sign up to view co-investors

16 co-investors across 16 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×6 · Private Equity ×3 · Hedge Fund ×3 · 1 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

HCRx on Indexed.vc
<a href="https://indexed.vc/investors/hcrx"><img src="https://indexed.vc/api/badge/investor/hcrx" alt="HCRx on Indexed.vc" width="260" height="76" /></a>